Avanos Medical reports Q3 2023 results; no financial details available in filing text

AVANOS MEDICAL, INC.

2023-Q3 EPS reported -$1.55 revenue$500,000,000

Filed 8-K on Nov 1, 2023 announcing Q3 earnings results for period ended Sept 30, 2023.
Press release issued as Exhibit 99.1 but not included in provided text.
Unable to extract revenue, EPS, or segment data from available information.
Recommend reviewing full press release for specific financial figures and guidance.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AVANOS MEDICAL, INC. reported financial results for the three and nine months ended September 30, 2023.

Period: the three and nine months ended September 30, 2023
Result: reported results

Exact text from the filing

Avanos Medical, Inc. (the “Company”) announced its results of operations for the three and nine months ended September 30, 2023 in a press release dated November 1, 2023.

View on SEC.gov

Browse all earnings releases →

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-23-000077

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.